Correlating Enzymes to Antimicrobial Resistance in the Protein Data Bank

Abstract

Antibiotic resistant bacteria are predicted to be the leading cause of death worldwide, with an expected death rate of 10 million people, annually, by 2050. It is vital that antimicrobial resistance (AMR) be understood at the molecular level. The Protein Data Bank (PDB) archive holds over 130,000 3D structures of macromolecular machines that can be analyzed using the RCSB PDB website at RCSB.org. Studying these 3D structures enables scientific research and education in a variety of fields, including drug discovery, nanotechnology, green energy, and disease. In this study, PDB enzymes related to antibiotic inhibitors were identified and further analyzed using additional bioinformatics including The Comprehensive Antibiotic Resistance Database (CARD). CARD holds up to date clinically relevant antibiotic related information. CARD identified 4,688 Genbank IDs (protein accession codes) that are related to AMR. These codes were then put into the Uniprot website which holds protein sequences. As a result, 696 macromolecules related to AMR were found in the PDB. I specifically researched Metallo Beta Lactamases (MBL) because have a large correlation to AMR and have been studied in great detail, with many examples in the PDB. Prominent enzymes in this category include the New Delhi Beta Lactamase which can cleave most if not all antibiotics. This particular “superbug” was found to cleave penicillin, cephalosporin, and carbapenem antibiotics. Using 3D visualizations of beta lactamase enzymes a correlation between zinc ions and spectrum of antibiotic resistance was found. For example, if an enzyme had two zinc ions instead of one it could inhibit broad spectrum antibiotics. In conclusion, the findings of this research presented here will be used to develop novel AMR tab at RCSB.org that will provide antimicrobial details of enzymes that were unavailable before. In the near future a phylogenetic tree of AMR related enzymes and classification details will be implemented.Support or Funding InformationRCSB PDB is funded by a grant from the National Science Foundation (DBI‐1338415), the National Institutes of Health, and the US Department of Energy.This abstract is from the Experimental Biology 2018 Meeting. There is no full text article associated with this abstract published in The FASEB Journal.